Academic Journal

E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models

التفاصيل البيبلوغرافية
العنوان: E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
المؤلفون: Bruun, Jarle, Eide, Peter Andreas Wold, Bergsland, Christian Holst, Brück, Oscar, Svindland, Aud, Arjama, Mariliina, Välimäki, Katja, Bjørnslett, Merete Pauline, Guren, Marianne, Kallioniemi, Olli, Nesbakken, Arild, Lothe, Ragnhild Adelheid, Pellinen, Teijo Severi
المصدر: Bruun, Jarle Eide, Peter Andreas Wold Bergsland, Christian Holst Brück, Oscar Svindland, Aud Arjama, Mariliina Välimäki, Katja Bjørnslett, Merete Pauline Guren, Marianne Kallioniemi, Olli Nesbakken, Arild Lothe, Ragnhild Adelheid Pellinen, Teijo Severi . E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Molecular Oncology. 2021, 1-18
Molecular Oncology
Relation: NFR/250993
الاتاحة: http://hdl.handle.net/10852/90823
https://www.duo.uio.no/bitstream/handle/10852/90823/1/Postnr%2B1976910_Bruun%2Bet%2Bal_Molecular%2BOncology%2B-%2BE%25E2%2580%2590cadherin%2Bis%2Ba%2Brobust%2Bprognostic%2Bbiomarker%2Bin%2Bcolorectal%2Bcancer%2Band%2Blow%2Bexpression%2Bis.pdf
قاعدة البيانات: NORA (Norwegian Open Research Archive)
الوصف
تدمد:18780261
DOI:10.1002/1878-0261.13159